Tango Therapeutics, Inc 10-K for FY2024
Tango Therapeutics, Inc. (TNGX)
10-K
2025-02-27
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Tango Therapeutics, Inc filed this 10-K on February 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $42.07M
- up 15.2% from $36.53M a year earlier
- Net loss
- $130.3M
- compared with a net loss of $101.74M a year earlier
- Diluted EPS
- -$1.19
- compared with -$1.08 a year earlier